Latest Feature

Podcast: Haemonetics CEO Brian Concannon at MassDevice.com's DeviceTalks

Haemonetics CEO Brian Concannon discusses how the company will transform blood management in the coming years at MassDevice.com's DeviceTalks Boston event.

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King

Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at De

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

FDA cybersecurity rejections are on the way

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Johnson & Johnson loses bids to dismiss Pinnacle bellwethers

July 28, 2014 by Brad Perriello

A federal judge in Texas shoots down Johnson & Johnson's bids to dismiss a pair of bellwether product liability lawsuits filed over its Pinnacle metal-on-metal hip implant.

Johnson & Johnson loses bids to dismiss Pinnacle bellwethers

Google dives deeper into health with human data project | MassDevice.com On Call

July 28, 2014 by Arezu Sarvestani

Google's clandestine "X" labs looks to collect and analyze human genomic and molecular data in search of patterns and irregularities that may point to disease.

MassDevice.com On Call

MASSDEVICE ON CALL — Technology titan Google (NSDQ:GOOG) is taking new interest in human health in the latest "moonshot" project coming out of its ambitious "X" lab, famous for self-driving cars and Google Glass.

Smith & Nephew CEO reveals new 'no frills' strategy

July 28, 2014 by Brad Perriello

Smith & Nephew CEO Olivier Bohuon reveals a new, 'no frills' strategy for developed markets that the company 1st pioneered in emerging markets.

Smith & Nephew CEO reveals new 'no frills' strategy

Medtronic, Lifetech expand China pacemaker deal

July 28, 2014 by Brad Perriello

Medtronic and Lifetech Scientific expand their deal to co-produce pacemakers for the Chinese market.

Medtronic, Lifetech expand China pacemaker deal

Skyline Medical raises funds to pay corporate salaries

July 25, 2014 by Arezu Sarvestani

Skyline Medical reveals in an SEC filing that it raised about $733,000 to help pay its officers and directors.

Skyline Medical raises funds to pay corporate salaries

Minnesota device maker issued a series of updates this month on its legal and financial dealings, including that it secured more than $733,000 to help pay for its corporate expenses.

AtriCure renews outlook on another strong quarter

July 25, 2014 by Arezu Sarvestani

AtriCure gets some Wall Street love after again boosting its full-year expectations on the back of a 30% boost in revenues in its 2nd quarter.

AtriCure renews outlook on another strong quarter

Ohio-based AtriCure (NSDQ:ATRC) gained a few points today as investors reacted to new of the company's Q2 financial report.

MassDevice.com +3 | The top 3 medtech stories for July 25, 2014

July 25, 2014 by MassDevice staff

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Medtronic settles insulin pump beef for $2.8M

July 25, 2014 by Arezu Sarvestani

Medtronic agrees to pay $2.8 million to close the books on a multi-state and federal lawsuit accusing the company of illegally soliciting insulin pump patients to replace their devices.

Medtronic settles insulin pump beef for $2.8M

Federal and state regulators agreed to a $2.8 million settlement with medtech titan Medtronic (NYSE:MDT) to close the books on a years-old concern over insulin infusion pumps.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp